Research Paper Volume 12, Issue 1 pp 912—930

Prognostic potential of PRPF3 in hepatocellular carcinoma

Figure 2. PRPF3 transcription in subgroups of patients with HCC, stratified based on gender, age and other criteria (UALCAN). Box-whisker plots showing the expression of PRPF3 in sub groups of LIHC samples. (A) Boxplot showing relative expression of PRPF3 in normal and LIHC samples. (B) Boxplot showing relative expression of PRPF3 in normal individuals of either gender and male or female LIHC patients, respectively. (C) Boxplot showing relative expression of PRPF3 in normal individuals of any age or in LIHC patients aged 21-40, 41-60, 61-80, or 81-100 yr. (D) Boxplot showing relative expression of PRPF3 in normal, African American, Caucasian and Asian LIHC patients. (E) Boxplot showing relative expression of PRPF3 in normal individuals or in LIHC patients in stages 1, 2, 3 or 4. (F) Boxplot showing relative expression of PRPF3 in normal individuals or LIHC patients with grade 1, 2, 3 or 4 tumors. The central mark is the median; the edges of the box are the 25th and 75th percentiles. The t-test was used to estimate the significance of difference in gene expression levels between groups. *, p < 0.05; **, p < 0.01; ***, p < 0.001.